Risk Factor Modification in Stroke Prevention
- 1 January 1999
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 30 (1), 16-20
- https://doi.org/10.1161/01.str.30.1.16
Abstract
[corrected] We reviewed Stroke Clinic data to determine the extent of risk factor modification achieved in patients with cerebrovascular disease over 2 years. Visits to the Stroke Clinic of a tertiary medical center from July 1, 1994, through June 30, 1996, were reviewed. Obesity, smoking, hypertension, hyperlipidemia, hyperglycemia, and lifestyle changes were noted in patients with >/=2 visits (n=61) and measures (number varied) of these parameters. Fifty-six patients (92%) had primary care physicians. In the 49 patients with >/=2 weight measurements, 33 (67%) were moderately or severely overweight by weight-height correlation. Forty-four patients (90%) remained in the same weight category. Of the 60 patients with available blood pressure data, 50 (83%) were hypertensive. At their last visits, 43 of the 50 (86%) were receiving medications, and 22 of the 43 treated (51%) were controlled. Serum glucose remained elevated in 14 of 47 patients (30%) and in 11 of 16 diabetic patients (69%). Thirty-six of 47 patients (55%) had elevated lipid measurements. None of the 21 smokers quit during the study period. Few patients modified dietary and exercise practices. Of 61 patients, 29 (48%) sustained vascular events during the study, with 17 of these 29 patients (59%) having strokes or transient ischemic attacks. Although most patients were asked to quit smoking, received advice regarding diet and exercise, and were medicated for hypertension, elevated glucose, and cholesterol levels, their risk factor profiles showed little improvement during the 2-year period. More effective methods of controlling stroke risk factors are needed.Keywords
This publication has 23 references indexed in Scilit:
- Stroke Prevention: Windows of Opportunity and Failed Expectations?Neuroepidemiology, 1997
- Logistics in Acute Stroke ManagementDrugs, 1997
- Neuroprotective Therapies In StrokeDrugs, 1997
- SummaryJournal Of Hypertension, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Differences between smokers, ex-smokers passive smokers and non-smokersJournal of Clinical Epidemiology, 1994
- What the experts think: A European survey of expert opinion about the influence of lifestyle on healthEuropean Journal of Epidemiology, 1994
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980